FormFactor, Inc.

Fundamentals8.0
Price Action7.0
News Sentiment7.0
AI Rating
7.0

Key Drivers

  • Low leverage
  • Modest ROE
  • High reinvestment

AI
AI Summary

7.0

FormFactor appears to be shifting from a cyclical probe‑card supplier to a higher‑margin, multi‑market test platform driven by HBM4 intensity and new products, but the investment hinges on concrete qualification wins, a successful Farmers Branch capacity ramp and sustained margin expansion (toward management's ~47% target) to justify its rich valuation—monitor near‑term HBM customer concentration, capex timing, and quarterly margin/cash‑flow evidence as the key make‑or‑break indicators.

HBM4
ExecutionRisk
BalanceSheet‍

Price Chart

Loading chart...

Financial Metrics

-
Revenue (TTM)
-
Net Income (TTM)
-
EPS (Q)
-
MCAP

Deep Analysis

Research tool. Not personalized advice.

Fundamental Analysis

8.0

Key Financial Insights:

  • Low leverage
  • Modest ROE
  • High reinvestment

FORM combines a very strong balance sheet and improving quarterly margins with low returns, heavy reinvestment and working-capital intensity, but is priced richly versus fundamentals.

BalanceSheetStrength
RichValuation

Price Behavior

7.0
Research tool. Not personalized advice. Technical analysis is for informational purposes only.

Key Price Behavior Insights:

  • Mild downtrend
  • Elevated volatility
  • Support holding

FORM shows a mild short‑term downtrend after a post‑spike pullback (close $92.22 just below the last month SMA ~$93.80) with modest negative momentum, high intraperiod volatility (high $105.83 to low $85.01) and nearby support at $85.01 versus resistance near $99.70–$105.83.

caution
watch
Support Level: $85.01
Resistance Level: $99.70–$105.83

Sharp swing from $105.83 to $85.01 in early

Sentiment & News

7.0

Key News Insights:

  • Strong share momentum
  • HBM4 demand thesis
  • Quantum product push

FormFactor's shares surged ~188% over six months on HBM4-driven demand expectations, new quantum test product launches and investor engagement, with only a modest institutional trim.

momentum
quantum

The combination of pronounced share-price momentum, product innovation and anticipated HBM4-driven test intensity supports upside for FORM, though investor monitoring of institutional flows remains warranted